Josephson, F., Allqvist, A., Janabi, M., Sayi, J., Aklillu, E., Jande, M., . . . Bertilsson, L. (2007). CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir. Clinical pharmacology & therapeutics, 81(5), . https://doi.org/https://doi.org/10.1038/sj.clpt.6100117
Chicago-Zitierstil (17. Ausg.)Josephson, Filip, et al. "CYP3A5 Genotype Has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir." Clinical Pharmacology & Therapeutics 81, no. 5 (2007). https://doi.org/https://doi.org/10.1038/sj.clpt.6100117.
MLA-Zitierstil (9. Ausg.)Josephson, Filip, et al. "CYP3A5 Genotype Has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir." Clinical Pharmacology & Therapeutics, vol. 81, no. 5, 2007, https://doi.org/https://doi.org/10.1038/sj.clpt.6100117.